We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Arbutus Biopharma
ABUS
$865M
| $64K | ﹤0.01% |
30,593
+8,797
| +40% | +$22.5K |
|
|
OSG
927
DELISTED
Overseas Shipholding Group Inc.
OSG
| $64K | ﹤0.01% |
33,939
-31,200
| -48% | -$57.8K |
|
|
CLUB
928
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $63K | ﹤0.01% |
28,922
-47,447
| -62% | -$159K |
|
|
APEN
929
DELISTED
Apollo Endosurgery, Inc.
APEN
| $62K | ﹤0.01% |
18,987
+1,983
| +12% | +$7.05K |
|
|
APTX
930
DELISTED
Aptinyx Inc. Common Stock
APTX
| $54K | ﹤0.01% |
+16,100
| New | +$57.2K |
|
|
CTG
931
DELISTED
Computer Task Group, Inc.
CTG
| $52K | ﹤0.01% |
12,845
-8,208
| -39% | -$35.4K |
|
|
EGIO
932
DELISTED
Edgio, Inc. Common Stock
EGIO
| $51K | ﹤0.01% |
474
-5,117
| -92% | -$611K |
|
933
Vaalco Energy
EGY
$594M
| $47K | ﹤0.01% |
27,933
-77,217
| -73% | -$151K |
|
|
PRCP
934
DELISTED
Perceptron Inc
PRCP
| $45K | ﹤0.01% |
+10,087
| New | +$59.7K |
|
935
Sportsman's Warehouse
SPWH
$43.7M
| $40K | ﹤0.01% |
+10,700
| New | +$45.5K |
|
|
NH
936
DELISTED
NantHealth, Inc
NH
| $27K | ﹤0.01% |
3,369
-8,533
| -72% | -$86.9K |
|
937
Ameris Bancorp
ABCB
$5.89B
| – | – |
-24,870
| Closed | -$854K |
|
938
Asbury Automotive
ABG
$4.19B
| – | – |
-18,380
| Closed | -$1.27M |
|
939
Arch Capital
ACGL
$36.1B
| – | – |
-6,610
| Closed | -$214K |
|
940
Axcelis
ACLS
$4.12B
| – | – |
-29,036
| Closed | -$584K |
|
941
Argan
AGX
$7.98B
| – | – |
-16,891
| Closed | -$844K |
|
942
Allient
ALNT
$1.47B
| – | – |
-73,145
| Closed | -$1.68M |
|
943
Alpha and Omega Semiconductor
AOSL
$923M
| – | – |
-42,891
| Closed | -$494K |
|
944
APA Corp
APA
$12.8B
| – | – |
-247,550
| Closed | -$8.58M |
|
945
Antero Resources
AR
$10.9B
| – | – |
-13,500
| Closed | -$119K |
|
946
Atkore
ATKR
$2.59B
| – | – |
-114,814
| Closed | -$2.47M |
|
947
Brunswick
BC
$5.19B
| – | – |
-127,798
| Closed | -$6.43M |
|
|
BELFB
948
Bel Fuse Inc Class B
BELFB
$3.88B
| – | – |
-38,804
| Closed | -$981K |
|
949
BJ's Restaurants
BJRI
$1.41B
| – | – |
-30,210
| Closed | -$1.43M |
|
950
Brookdale Senior Living
BKD
$3.62B
| – | – |
-148,322
| Closed | -$976K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.